| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |